Cystic fibrosis Patients' COVID antibodies under microscope
NCT ID NCT05074680
First seen Jun 07, 2026 · Last updated Jun 13, 2026 · Updated 2 times
Summary
This study looked at whether people with cystic fibrosis (CF) develop antibodies after COVID-19 infection or vaccination. Researchers followed 5 participants for 2 years, taking blood samples and tracking lung health. The goal was to understand how CF affects COVID-19 risk and immune response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University Children's hospital Bern
Bern, 3010, Switzerland
-
University Children's hospital, Zürich
Zurich, 8032, Switzerland
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.